Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved
It opens the door to more scrutiny of how telehealth and compounding companies market GLP-1s, especially when they blur the lines between compounded products and FDA-approved drugs
Additionally, combining semaglutide with other GLP-1 receptor agonists (such as dulaglutide, liraglutide, or tirzepatide) significantly increases the risk of severe nausea, vomiting, and gastrointestinal complications
Medical Coordination Berberine can interact with medications, particularly diabetes drugs, potentially causing excessive blood sugar lowering when combined with metformin or other glucose-lowering agents 29 Yin, J